161892
Epidemiology as a Policy Tool
Tuesday, November 6, 2007
Dave Cundiff, MD, MPH
,
Cundiff and Associates, Olympia, WA
The American Association of Public Health Physicians (AAPHP), with funding from CDC, has developed an educational curriculum which we call the Preventive Services ToolKit. One educational module deals with Epidemiology as a Policy Tool. This interactive module is intended to enable and empower epidemiologists and other health professionals using selected epidemiologic methods to define healthcare and public health policy intiatives and translate their recommendations into policy, programming and budgetary action at facility, local and state levels. This presentation will focus on these epi methods, how they differ from research methodology, and present examples of how they have been and can be used to influence policy, programming and budget.
Learning Objectives: 1. Recognize and articulate the ways in which epidemiologic studies can and should be used to influence public health and healthcare policy, programming and budgeting at facility, local and state levels.
2. Discuss the differences in methodology between epidemiologic study for research and epidemiologic studies done to influence policy, programming and budgeting.
3. Discuss the ways in which findings of epidemiologic studies can be translated into new or modified policies or programming at facility, local and state levels.
4. Discuss methods that can be used to educate non-medical-professional policymakers and administrators can be educated as to the value of epidemiologic study for purposes of policy and program development, budgeting, feasibility study, program planning and program evaluation.
5. Discuss the methods recommended in this presentation to the newly proposed CSTE Comendium of Competencies for Epidemiologists
Keywords: Public Policy, Advocacy
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|